Prophylaxis, diagnosis and therapy of hepatitis B virus (HBV) infection: The German guidelines for the management of HBV infection

被引:50
作者
Cornberg, M. [1 ]
Protzer, U. [2 ]
Dollinger, M. M. [3 ]
Petersen, J. [4 ]
Wedemeyer, H. [1 ]
Berg, T. [5 ]
Jilg, W. [6 ]
Erhardt, A. [7 ]
Wirth, S. [8 ]
Schirmacher, P. [9 ]
Fleig, W. E. [10 ]
Manns, M. P. [1 ]
机构
[1] Hannover Med Sch, Abt Gastroenterol Hepatol & Endokrinol, D-30625 Hannover, Germany
[2] Tech Univ Munich, Helmholtz Zentrum Munchen, Inst Virol, D-8000 Munich, Germany
[3] Univ Halle Wittenberg, Klin & Poliklin Innere Med 1, D-4010 Halle, Germany
[4] Univ Klinikum Hamburg Eppendorf, Med Klin & Poliklin 1, Hamburg, Germany
[5] Humboldt Univ, Charite, Med Klin MS Hepatol & Gastroenterol, D-1086 Berlin, Germany
[6] Univ Regensburg, Inst Med Mikrobiol & Hyg, D-8400 Regensburg, Germany
[7] Univ Dusseldorf, Univ Klin Dusseldorf, Klin Gastroenterol Hepatol & Infektiol, D-4000 Dusseldorf, Germany
[8] Univ Witten Herdecke, HELIOS Klinikum Wuppertal, Zentrum Kinder & Jugendmed, Witten, Germany
[9] Univ Klinikum Heidelberg, Inst Pathol, Heidelberg, Germany
[10] Univ Leipzig, Univ Klinikum, Leipzig, Germany
来源
ZEITSCHRIFT FUR GASTROENTEROLOGIE | 2007年 / 45卷 / 12期
关键词
D O I
10.1055/s-2007-963714
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
[No abstract available]
引用
收藏
页码:1281 / 1328
页数:48
相关论文
共 497 条
[41]   HEPATITIS-B VIRUS ASSOCIATED COINFECTION AND SUPERINFECTION WITH SIGMA-AGENT - INDISTINGUISHABLE DISEASE WITH DIFFERENT OUTCOME [J].
CAREDDA, F ;
ROSSI, E ;
MONFORTE, AD ;
ZAMPINI, L ;
RE, T ;
MERONI, B ;
MORONI, M .
JOURNAL OF INFECTIOUS DISEASES, 1985, 151 (05) :925-928
[42]  
Carlsson T, 1999, SCAND J INFECT DIS, V31, P93, DOI 10.1080/00365549950161961
[43]   Clinical impact and efficacy of lamivudine therapy in de Novo hepatitis B infection after liver transplantation [J].
Castells, L ;
Vargas, V ;
Rodríguez, F ;
Allende, H ;
Buti, M ;
Sánchez-Avila, JF ;
Jardí, R ;
Margarit, C ;
Pumarola, T ;
Esteban, R ;
Guardia, J .
LIVER TRANSPLANTATION, 2002, 8 (10) :892-900
[44]   Efficacy of peginterferon alpha-2b in chronic hepatitis delta:: Relevance of quantitative RT-PCR for follow-up [J].
Castelnau, Corinne ;
Le Gal, Frederic ;
Ripault, Marie-Pierre ;
Gordien, Emmanuel ;
Martinot-Peignoux, Michelle ;
Boyer, Nathalie ;
Pham, Bach-Nga ;
Maylin, Sarah ;
Bedossa, Pierre ;
Deny, Paul ;
Marcellin, Patrick ;
Gault, Elyanne .
HEPATOLOGY, 2006, 44 (03) :728-735
[45]  
*CDC, 2004, REC HEP B VACC RISK
[46]   Is vaccination against hepatitis B infection indicated in patients waiting for or after orthotopic liver transplantation? [J].
Chalasani, N ;
Smallwood, G ;
Halcomb, J ;
Fried, MW ;
Boyer, TD .
LIVER TRANSPLANTATION AND SURGERY, 1998, 4 (02) :128-132
[47]   A randomized, controlled trial of combination therapy for chronic hepatitis B:: Comparing pegylated interferon-α2b and lamivudine with lamivudine alone [J].
Chan, HLY ;
Leung, NWY ;
Hui, AY ;
Wong, VWS ;
Liew, CT ;
Chim, AML ;
Chan, FKL ;
Hung, LCT ;
Lee, YT ;
Tam, JSL ;
Lam, CWK ;
Sung, JJY .
ANNALS OF INTERNAL MEDICINE, 2005, 142 (04) :240-250
[48]   The efficacy of thymosin in the treatment of chronic hepatitis B virus infection: a meta-analysis [J].
Chan, HLY ;
Tang, JL ;
Tam, W ;
Sung, JJY .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2001, 15 (12) :1899-1905
[49]   Durability of HBeAg seroconversion after adefovir dipivoxil treatment for chronic hepatitis B (CHB) [J].
Chang, TT ;
Shiffman, M ;
Tong, M ;
Marcellin, P ;
Liaw, YF ;
Luengrojanakul, P ;
Choy, GS ;
James, C ;
Ma, I ;
Xiong, S ;
Currie, G ;
Brosgart, CL .
JOURNAL OF HEPATOLOGY, 2004, 40 :126-126
[50]   A comparison of entecavir and lamivudine for HBeAg-positive chronic hepatitis B [J].
Chang, TT ;
Gish, RG ;
de Man, R ;
Gadano, A ;
Sollano, J ;
Chao, YC ;
Lok, AS ;
Han, KH ;
Goodman, Z ;
Zhu, J ;
Cross, A ;
DeHertogh, D ;
Wilber, R ;
Colonno, R ;
Apelian, D .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (10) :1001-1010